|
NevanacDrug - Nevanac The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Nepafenac
Strength -
0.1%
Applicant -
ALCON
New Drug Application (NDA) Number -
021862
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 19, 2005
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Alcon Inc
Nevanac
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical Nevanac 0.1% Suspension/drops; Ophthalmic Neo-delta-cortef Eq 3.5mg Base/gm;0.5% Ointment; Ophthalmic Neo-delta-cortef Eq 3.5mg Base/ml;0.25% Suspension/drops; Ophthalmic Neo-hydeltrasol Eq 3.5mg Base/gm;eq 0.25% Phosphate Ointment; Ophthalmic Mytrex A Eq 3.5mg Base/gm;0.1% Cream; Topical Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Cream; Topical Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Cream; Topical Mytrex A Eq 3.5mg Base/gm;0.1% Ointment; Topical NewDrugInformation |